Brand Name
Naropin_®

Ropivacaine HCl Injection

Better Anesthetic Experience for Patients

Anesthesiologists, Interventional Pain Physicians, Interventional Radiologists, and Neurosurgeons have been using Naropin since 1997 for its dependable and consistent delivery of effective local and regional anesthesia for surgery and acute pain management. This analgesic has an 18% to 52% faster onset than bupivicaine, but variations in onset and duration will occur depending on the dose rate and route of administration. This anesthetic is also known to have more successful post-op results as patients receiving Naropin rated their overall anesthesia experience as excellent compared to patients administered bupivicaine.